Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Kenneth Lloyd"'
Autor:
Yuxin Hao, Jiabin Yan, Courtney Fraser, Aiping Jiang, Murali Anuganti, Roushu Zhang, Kenneth Lloyd, Joseph Jardine, Jessica Coppola, Rob Meijers, Jing Li, Timothy A. Springer
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
Integrins are cell surface receptors that mediate the interactions of cells with their surroundings and play essential roles in cell adhesion, migration, and homeostasis. Eight of the 24 integrins bind to the tripeptide Arg-Gly-Asp (RGD) motif in the
Externí odkaz:
https://doaj.org/article/cf98f9e736e742c0b512e4f1ef781a2c
Autor:
Reimer, Kenneth Lloyd1
Publikováno v:
Journal of Academic Perspectives. 2024, Issue 2, p167-176. 10p.
Autor:
Kimberley Davies, Chloe Gott, Anna Ferdman, Kenneth Lloyd, Nefeli Pnevmatikos, Emma Chase, Julia Lappin
Publikováno v:
Australian Psychologist. :1-6
Autor:
Marina Natoli, Petra Herzig, Elham Pishali Bejestani, Melanie Buchi, Reto Ritschard, G. Kenneth Lloyd, Ramon Mohanlal, James R. Tonra, Lan Huang, Viola Heinzelmann, Marta Trüb, Alfred Zippelius, Abhishek S. Kashyap
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Reprogramming tumor infiltrating myeloid cells to elicit pro-inflammatory responses is an exciting therapeutic maneouver to improve anti-tumor responses. We recently demonstrated that a distinct microtubule-targeting drug, plinabulin—a clinical-sta
Externí odkaz:
https://doaj.org/article/d21b4ca37c104d1593f619178ef9f5c2
Treg cells drive MYCN-mediated immunosuppression and tumor aggressiveness in high-risk neuroblastoma
Autor:
Xiaodan Qin, Andrew Lam, Xu Zhang, Satyaki Sengupta, J. Bryan Iorgulescu, Tao Zuo, Alexander E. Floru, Grace Meara, Liang Lin, Kenneth Lloyd, Lauren Kwok, Kaylee Smith, Raghavendar T. Nagaraju, Rob Meijers, Craig Ceol, Ching-Ti Liu, Sanda Alexandrescu, Catherine J. Wu, Derin B. Keskin, Rani E. George, Hui Feng
Solid tumors, especially those with aberrant MYCN activation, harbor an immunosuppressive microenvironment to fuel malignant growth and trigger treatment resistance1,2, yet the underlying mechanisms are elusive and effective strategies to tackle this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63883130467fe2677d688fca7628f12
https://doi.org/10.1101/2022.10.03.510561
https://doi.org/10.1101/2022.10.03.510561
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Chemotherapy-induced neutropenia (CIN) increases the risk of infections and mortality in cancer patients. G-CSF therapies are approved for the treatment of CIN, but non-G-CSF therapies are needed to increase efficacy and minimize side effects
Autor:
Rider, Kenneth Lloyd
Publikováno v:
Management Science, 1976 Oct 01. 23(2), 146-158.
Externí odkaz:
https://www.jstor.org/stable/2629822
Autor:
Paul J. Rozance, Timothy M. Crombleholme, Jason Gien, Cristina M. Alvira, Kenneth Lloyd Jones, Steven H. Abman, Gregory J. Seedorf, Kyle N Powers, David P. Astling, R. Blair Dodson
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 315:L348-L359
Intrauterine growth restriction (IUGR) in premature newborns increases the risk for bronchopulmonary dysplasia, a chronic lung disease characterized by disrupted pulmonary angiogenesis and alveolarization. We previously showed that experimental IUGR
Autor:
Lihua Du, Yanping Wu, Jessica Dalsing-Hernandez, Mary Ann Jordan, Leslie Wilson, Steffan T. Nawrocki, Kari Kotlarczyk, Jamie Bishop, Lan Huang, Paul Gonzales, Hans-Georg Wirsching, Patrick J. Cimino, G. Kenneth Lloyd, Jennifer S. Carew
Publikováno v:
Biomedical Reports
Constitutive activation of Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most common oncogenic event in certain types of human cancer and is associated with poor patient survival. Small molecule signaling inhibitors have improved the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca1f4f2c6a3d41c3906e2899c52aa8f7
https://www.zora.uzh.ch/id/eprint/176137/
https://www.zora.uzh.ch/id/eprint/176137/
Autor:
Michel O. Steinmetz, G. Kenneth Lloyd, Francisco de Asis Balaguer Perez, Lan Huang, Giuseppina La Sala, Andrea Cavalli, Natacha Olieric, Federica Viti, José Fernando Díaz, Ashwani Sharma, Sergio Decherchi, James R. Tonra
Publikováno v:
Chem (Cambridge. Print) 5 (2019): 2969–2986. doi:10.1016/j.chempr.2019.08.022
info:cnr-pdr/source/autori:La Sala G.; Olieric N.; Sharma A.; Viti F.; de Asis Balaguer Perez F.; Huang L.; Tonra J.R.; Lloyd G.K.; Decherchi S.; Diaz J.F.; Steinmetz M.O.; Cavalli A./titolo:Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes/doi:10.1016%2Fj.chempr.2019.08.022/rivista:Chem (Cambridge. Print)/anno:2019/pagina_da:2969/pagina_a:2986/intervallo_pagine:2969–2986/volume:5
Digital.CSIC. Repositorio Institucional del CSIC
instname
info:cnr-pdr/source/autori:La Sala G.; Olieric N.; Sharma A.; Viti F.; de Asis Balaguer Perez F.; Huang L.; Tonra J.R.; Lloyd G.K.; Decherchi S.; Diaz J.F.; Steinmetz M.O.; Cavalli A./titolo:Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes/doi:10.1016%2Fj.chempr.2019.08.022/rivista:Chem (Cambridge. Print)/anno:2019/pagina_da:2969/pagina_a:2986/intervallo_pagine:2969–2986/volume:5
Digital.CSIC. Repositorio Institucional del CSIC
instname
25 p.-5 fig.-1 tab. + 6 fig. supl.+ 1 tab. supl.
αβ-Tubulin is a validated target for anticancer drug discovery, and molecules binding to this protein are used to treat several types of tumors. Here, we report on a combined X-ray crystallograp
αβ-Tubulin is a validated target for anticancer drug discovery, and molecules binding to this protein are used to treat several types of tumors. Here, we report on a combined X-ray crystallograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b99b1daca5dd2565c568532d8c33feb
http://www.cnr.it/prodotto/i/449379
http://www.cnr.it/prodotto/i/449379